Eyestem Research Pvt Ltd announced positive results from its phase 1/2 trial ( NCT06394232) evaluating its investigational ...

If you or a loved one has been diagnosed with geographic atrophy, it can help to understand a bit more about the condition, ...

Eyestem will be presenting its data at the ARVO 2025 Annual Meeting as well as the 10th Retinal Cell and Gene Therapy ...

patients with geographic atrophy (GA) are likely to experience progressive vision loss. The quality of life and functional performance of people with vision loss can be improved through the ...

Geographic atrophy is an advanced form of dry age-related macular degeneration that causes vision loss in older adults. Until recently, there were no treatments available to target the root cause.

A bioengineered RPE stem cell-derived retinal implant has shown ability to partially restore vision in geographic atrophy. SEVILLE, Spain — A cell-based subretinal implant shows promise in the ...

Geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD), leads to significant progressive vision loss and blindness. With a rise in the aging population around the ...

is pleased to announce significant vision improvement in Phase 1 trials of its investigational drug, Eyecyte-RPE™, in patients with geographic atrophy (GA) secondary to dry age-related macular ...

Average improvement of 14.9 letters in visual acuity reported in the first six patients over a four-six month follow-up. Signs of disease reversal observed in some patients. Dr Jogin Desai, Founder ...